Bill Hearl is CEO and founder of Immunomic Therapeutics in Rockville.
COURTESY IMMUNOMIC THERAPEUTICS

The latest funding comes on top of $61.3 million in new funding the local biotech raised in April.

Image: Bill Hearl is CEO and founder of Immunomic Therapeutics in Rockville. COURTESY IMMUNOMIC THERAPEUTICS